The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network is delighted to announce the publication of results from IMPAACT P1093 in the May 2022 edition of The Lancet HIV.
IMPAACT 2017 (MOCHA) Data Informs U.S. FDA Approval of Cabenuva for HIV Treatment in Virologically Suppressed Adolescents
The IMPAACT Network is committed to conducting high quality clinical trials that will advance the prevention and treatment of HIV and its complications for infants, children, adolescents, and pregnant/postpartum women globally. Our research agenda includes four scientific specific aims.
The IMPAACT Network is always working on many studies at one time in the areas of treatment, tuberculosis, ART-free remission, and complications.
IMPAACT is a global network with sites all over the world in 12 countries.